Loading...
XSHE
300653
Market cap367mUSD
Jul 10, Last price  
14.48CNY
1D
3.28%
1Q
-26.72%
IPO
75.44%
Name

Yantai Zhenghai Bio-Tech Co Ltd

Chart & Performance

D1W1MN
XSHE:300653 chart
P/E
31.21
P/S
7.06
EPS
0.46
Div Yield, %
3.28%
Shrs. gr., 5y
-0.02%
Rev. gr., 5y
-1.87%
Revenues
364m
+0.25%
59,296,05777,376,969105,304,734128,132,520150,622,517182,782,114215,543,619279,807,036293,281,582400,175,251433,224,730433,224,730413,652,709363,225,350364,138,509
Net income
82m
-38.79%
8,515,11815,767,29533,660,49542,492,18445,470,11761,669,56285,815,070107,386,392118,333,989168,552,589185,436,805185,436,809190,957,573134,639,10882,410,131
CFO
97m
-35.80%
22,619,39534,383,49430,791,51245,739,64249,249,89765,473,42077,466,025103,477,376118,432,079166,134,014187,838,040180,477,811151,383,95597,190,675
Dividend
May 27, 20250.46 CNY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Yantai Zhenghai Biotechnology Co., Ltd., founded in 2003 and based in Yantai, China, specializes in the innovation, manufacturing, and commercialization of regenerative medical materials across China. The company's product offerings include a bone repair material, which is a partially deproteinized substance derived from calf cancellous bone after undergoing a series of processes like decellularization and degreasing. It also provides membranes for oral cavity repair, specifically designed to address shallow soft tissue defects in the mouth. Under the "Heal-All" brand, it supplies biomembranes used in neurosurgical procedures to mend defects of the cerebral dura mater. Additionally, the "Heal-Full" brand encompasses skin repair membranes developed for treating wounds within the dermal layer.
IPO date
May 16, 2017
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122023‑002022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT